Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Renal transplant

Not recruiting

Registered drugNo placebo

Study to Evaluate the Effectiveness of Pre-emptive Genotyping to Optimize Tacrolimus Dosage in Patients with Chronic Kidney Disease Awaiting Transplant

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Tacrolimus

Contact Research Centre

Soft tissue sarcoma

Not recruiting

InvestigationalNo placebo

Study of Cirtuvivint for Patients with Advanced Soft-Tissue Sarcomas as a Second-Line Treatment

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:CIRTUVIVINT

Contact Research Centre

Lupus nephritis

Not recruiting

Registered drug

Study on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Giant cell arteritis

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Upadacitinib and Prednisolone in Patients with Giant Cell Arteritis

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Prednisolone

Contact Research Centre

Hyperoxaluria

Not recruiting

InvestigationalNo placebo

Long-Term Safety and Efficacy Study of Nedosiran Injection for Patients with Primary Hyperoxaluria

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Nedosiran

Contact Research Centre

Breast cancer+7

Not recruiting

Registered drugNo placebo

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Gastrointestinal stromal tumour

Not recruiting

Registered drugNo placebo

Study Comparing Ripretinib and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors Previously Treated with Imatinib

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ripretinib

Contact Research Centre

Gastrointestinal stromal tumour

Not recruiting

Registered drugNo placebo

Study on the Effect of Extending Imatinib Treatment from Three to Five Years for Patients with High-Risk Gastrointestinal Stromal Tumor (GIST)

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Imatinib

Contact Research Centre

Breast cancer+3

Not recruiting

Registered drug

Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Capivasertib

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Registered drug

Study on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Breast cancer

Not recruiting

Registered drug

Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Hormone receptor positive breast cancer

Not recruiting

Registered drugNo placebo

Study of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Find therapies in clinical trials near you – page 3

56 trials match your criteria

Renal transplant

Study to Evaluate the Effectiveness of Pre-emptive Genotyping to Optimize Tacrolimus Dosage in Patients with Chronic Kidney Disease Awaiting Transplant

Soft tissue sarcoma

Study of Cirtuvivint for Patients with Advanced Soft-Tissue Sarcomas as a Second-Line Treatment

Lupus nephritis

Study on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis

Giant cell arteritis

Study on the Safety and Effectiveness of Upadacitinib and Prednisolone in Patients with Giant Cell Arteritis

Hyperoxaluria

Long-Term Safety and Efficacy Study of Nedosiran Injection for Patients with Primary Hyperoxaluria

Breast cancer+7

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Gastrointestinal stromal tumour

Study Comparing Ripretinib and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors Previously Treated with Imatinib

Gastrointestinal stromal tumour

Study on the Effect of Extending Imatinib Treatment from Three to Five Years for Patients with High-Risk Gastrointestinal Stromal Tumor (GIST)

Breast cancer+3

Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

HER2 positive breast cancer

Study on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy

Breast cancer

Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy

Hormone receptor positive breast cancer

Study of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.